Second throw of the dice unsuccessful: Full Federal Court confirms Hepatitis C drug patent is invalid
21 December 2017
The recent decision of the Full Court in Idenix Pharmaceuticals v Gilead Sciences [2017] FCAFC 196 illustrates the power of the grounds of lack of utility and lack of sufficiency under section 40 of the Patents Act when challenging the validity of a patent.
Read on